ArticleMolecular oncology2018

A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.

Sipeng Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.